Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5444
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLahari Sidde-
dc.date.accessioned2026-06-27T08:26:59Z-
dc.date.available2026-06-27T08:26:59Z-
dc.date.issued2026-06-27-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5444-
dc.descriptionVol. 35, No. 2, p 369en_US
dc.language.isoenen_US
dc.subjectAnti-breast canceren_US
dc.subjectCell linesen_US
dc.subjectIn vitroen_US
dc.subjectIn vivo modelsen_US
dc.subjectSignaling pathwayen_US
dc.subjectSyntheretic drugsen_US
dc.titleAdvances in heterocyclic compounds for breast cancer treatment : A compreshensive reviewen_US
dc.typeOtheren_US
Appears in Collections:Vol. 35, No. 2, 2025

Files in This Item:
File Description SizeFormat 
1.jpegVol. 35, No. 2, p 369233.19 kBJPEGView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.